COVID-19 vaccine surveillance reports (weeks 19 to 38)
Data on the real-world effectiveness and impact of the COVID-19 vaccines.
Updates to this page
- From:
- Public Health England
- Published:
- 14 May 2021
- Last updated:
-
23 September 2021
Show all updates
-
Added week 38 report.
-
Updated formatting of Table 3 in week 37 report.
-
Added COVID-19 vaccine surveillance report: 16 September 2021 (week 37).
-
Updated Table 6 and Figure 2(d) in week 36 report.
-
Added COVID-19 vaccine surveillance report: 9 September 2021 (week 36).
-
Added COVID-19 vaccine surveillance report: 2 September 2021 (week 35).
-
Added COVID-19 vaccine surveillance report: 26 August 2021 (week 34).
-
Added week 33 report: vaccine coverage updated.
-
Added COVID-19 vaccine surveillance report: 19 August 2021 (week 33).
-
Added COVID-19 vaccine surveillance report: 12 August 2021 (week 32).
-
Added COVID-19 vaccine surveillance report: 5 August 2021 (week 31).
-
Added week 30 report.
-
Added COVID-19 vaccine surveillance report: 22 July 2021 (week 29).
-
Added COVID-19 vaccine surveillance report: 15 July 2021 (week 28).
-
Added COVID-19 vaccine surveillance report: 8 July 2021 (week 27).
-
Added COVID-19 vaccine surveillance report: 1 July 2021 (week 26).
-
Added latest weekly report.
-
Updated figure 1a in the COVID-19 vaccine surveillance report: 17 June 2021 (week 24).
-
Added COVID-19 vaccine surveillance report: 17 June 2021 (week 24).
-
Added COVID-19 vaccine surveillance report: 10 June 2021 (week 23).
-
Added COVID-19 vaccine surveillance report: 3 June 2021 (week 22).
-
Added COVID-19 vaccine surveillance report: 27 May 2021 (week 21).
-
Added COVID-19 vaccine surveillance report: 20 May 2021 (week 20).
-
First published.
-
Documents
COVID-19 vaccine surveillance report: 23 September 2021 (week 38)
Ref: PHE publications gateway number: GOV-9885
PDF, 2.3 MB, 33 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
COVID-19 vaccine surveillance report: 16 September 2021 (week 37)
Ref: PHE gateway number GOV-9794
PDF, 1.29 MB, 33 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
COVID-19 vaccine surveillance report: 9 September 2021 (week 36)
Ref: PHE publications gateway number: GOV-9692
PDF, 1.21 MB, 33 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
COVID-19 vaccine surveillance report: 2 September 2021 (week 35)
Ref: PHE gateway number GOV-9606
PDF, 1.23 MB, 25 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
COVID-19 vaccine surveillance report: 26 August 2021 (week 34)
PDF, 1.6 MB, 24 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
COVID-19 vaccine surveillance report: 19 August 2021 (week 33)
Ref: PHE gateway number GOV-9429
PDF, 1.16 MB, 24 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
COVID-19 vaccine surveillance report: 12 August 2021 (week 32)
Ref: PHE publications gateway number: GOV-9343
PDF, 2.07 MB, 24 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
COVID-19 vaccine surveillance report: 5 August 2021 (week 31)
Ref: PHE gateway number GOV-9268
PDF, 3.78 MB, 24 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
COVID-19 vaccine surveillance report: 29 July 2021 (week 30)
Ref: PHE publications gateway number: GOV-9196
PDF, 1.88 MB, 24 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
COVID-19 vaccine surveillance report: 22 July 2021 (week 29)
Ref: PHE gateway number: GOV-9112
PDF, 972 KB, 24 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
COVID-19 vaccine surveillance report: 15 July 2021 (week 28)
Ref: PHE gateway number GOV-9000
PDF, 1.15 MB, 24 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
COVID-19 vaccine surveillance report: 8 July 2021 (week 27)
Ref: PHE gateway number GOV-8931
PDF, 1.23 MB, 25 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
COVID-19 vaccine surveillance report: 1 July 2021 (week 26)
Ref: PHE gateway number GOV-8845
PDF, 893 KB, 28 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
COVID-19 vaccine surveillance report: 24 June 2021 (week 25)
Ref: PHE gateway number GOV-8765
PDF, 895 KB, 22 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
COVID-19 vaccine surveillance report: 17 June 2021 (week 24)
Ref: PHE gateway number GOV-8694
PDF, 917 KB, 22 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
COVID-19 vaccine surveillance report: 10 June 2021 (week 23)
Ref: PHE publications gateway number: GOV-8620
PDF, 1.1 MB, 22 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
COVID-19 vaccine surveillance report: 3 June 2021 (week 22)
Ref: PHE publications gateway number: GOV-8544
PDF, 860 KB, 23 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
COVID-19 vaccine surveillance report: 27 May 2021 (week 21)
Ref: PHE gateway number GOV-8481
PDF, 1.11 MB, 21 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
COVID-19 vaccine surveillance report: 20 May 2021 (week 20)
Ref: PHE gateway number GOV-8401
PDF, 985 KB, 22 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
COVID-19 vaccine surveillance report: 13 May 2021 (week 19)
Ref: PHE gateway number GOV-8305
PDF, 4.08 MB, 19 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
Details
Since the beginning of the programme, Public Health England (PHE) has been monitoring the effectiveness of the vaccines in the real world as set out in the COVID-19 vaccine surveillance strategy and the impact on:
- symptomatic disease
- hospitalisation
- death
- infection (symptomatic or asymptomatic)
- transmission
Further reports on monitoring of the effectiveness of COVID-19 vaccination have been published.
Reports from week 39 are available and reports prior to week 19 are available as part of the National flu and COVID-19 surveillance reports.